Skip to content
Back to Guavy Wire
Stocks

Amgen Expands Global R&D Network with New Science Center in Hyderabad

Instruments
AMGN
Share

Biotech giant Amgen is expanding its global research and development network by opening a new Science & Innovation Center in Genome Valley, Hyderabad. The center will join seven other research laboratories operated by the company worldwide, further enhancing its research capabilities.

The new facility reflects Amgen's continued focus on harnessing biology and technology to fight tough diseases. By integrating advanced scientific capabilities with data and digital innovation, the company aims to accelerate the discovery and development of innovative medicines for patients globally.

Amgen's executive vice president of Research and Development, Jay Bradner, said that the new center will connect experimental science with data and technology across the company's global research capabilities. This integration is expected to enable faster learning and translation of insights into innovative medicines for patients.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc